Advanced Detection Technology for Ultra-Sensitive Biomarker Analysis in Research and Clinical Diagnostics
Chemiluminescent immunoassay (CLIA) represents a technological advancement that transforms biomarker quantification through light-emission-based detection platforms. Unlike traditional colorimetric ELISA relying on optical density measurements, chemiluminescent immunoassay kit systems detect actual photon emission generated during enzyme-catalyzed…